UK Practice Guidance (UPG2) - Dexamethasone induced Bone loss

This post addresses dexamethasone induced bone loss and enlists measures intended to counter it. It draws from specific UK based guidance which has been listed as a reference.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-06-24
DOI
https://doi.org/10.5281/zenodo.20828598
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UK Practice Guidance (UPG2) - Dexamethasone induced Bone loss

Rahul D Arora
Zenodo (CERN European Organization for Nuclear Research)
Bone health and osteoporosis research
article

UK Practice Guidance (UPG2) - Dexamethasone induced Bone loss

Rahul D Arora
article en

Abstract

This post addresses dexamethasone induced bone loss and enlists measures intended to counter it. It draws from specific UK based guidance which has been listed as a reference.

Zenodo (CERN European Organization for Nuclear Research)
M S Ramaiah Memorial Hospital (IN)
Openalex Percentile: Top 6%
Bone health and osteoporosis research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

UK Practice Guidance (UPG2) - Dexamethasone induced Bone loss — Rahul D Arora · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS